Find clinical trials for Pancreatic Cancer in Atlanta, GA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Pancreatic Cancer trials near Atlanta, GA, USA:
This is a multi-center clinical study enrolling up to 30 participants (15 patients in each cohort). The primary objective of the study is to evaluate...
Atlanta, Georgia, United States and 14 other locations
Antroquinonol is proposed for the treatment of neoplasms. The proposed clinical trial is a Phase I/II study designed to evaluate antroquinon ...
Phase 1, Phase 2
Newnan, Georgia, United States and 8 other locations
Zolbetuximab is being studied as a treatment for people with pancreatic cancer. Most people with pancreatic cancer...
Phase 2
Newnan, Georgia, United States and 135 other locations
This phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread...
Phase 2
Atlanta, Georgia, United States and 108 other locations
The purpose of this study is to evaluate the efficacy of an investigational RAS(ON) inhibitor administered in combination with chemotherapy compared...
Phase 3
Atlanta, Georgia, United States and 2 other locations
The purpose of this study is to evaluate the safety and efficacy of atebimetinib in combination with modified GnP compared with SOC GnP alone.
Phase 3
Atlanta, Georgia, United States and 18 other locations
The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard of care (SOC) observation only.
Phase 3
Atlanta, Georgia, United States and 33 other locations
irinotecan work in treating patients with gastrointestinal cancers that have spread to other places in the body (metastatic) or cannot be re...
Phase 1, Phase 2
Atlanta, Georgia, United States and 2 other locations
Evaluate the safety and tolerability of RMC-6236 in adults with specific RAS mutant advanced solid tumors....
Phase 1, Phase 2
Atlanta, Georgia, United States and 20 other locations
to assess the safety, tolerability, PK, PD, immunogenicity and anti-tumor activity of zenocutuzumab (MCLA-128) in patients with solid tumors...
Phase 2
Atlanta, Georgia, United States and 64 other locations
Clinical trials
Research sites
Resources
Legal